Citation: D. Reintgen, Expanding indications for lymphatic lymph node biopsy in the breast mapping and sentinel cancer population, ANN SURG O, 8(9), 2001, pp. 687-687
Citation: D. Reintgen, Judging the therapeutic value of lymph node dissections for melanaoma - Invited commentary, J AM COLL S, 191(1), 2000, pp. 22-23
Authors:
Balch, CM
Buzaid, AC
Atkins, MB
Cascinelli, N
Coit, DG
Fleming, ID
Houghton, A
Kirkwood, JM
Mihm, MF
Morton, DL
Reintgen, D
Ross, MI
Sober, A
Soong, SJ
Thompson, JA
Thompson, JF
Gershenwald, JE
McMasters, KM
Citation: Cm. Balch et al., A new American Joint Committee on Cancer staging system for cutaneous melanoma, CANCER, 88(6), 2000, pp. 1484-1491
Citation: D. Reintgen, The role of elective lymph node dissection in malignant melanoma: Who should undergo this nodal staging procedure?, J AM COLL S, 189(2), 1999, pp. 224-232
Citation: D. Reintgen et S. Shivers, Sentinel lymph node micrometastasis from melanoma - Proven methodology andevolving significance, CANCER, 86(4), 1999, pp. 551-552
Authors:
Morton, DL
Thompson, JF
Essner, R
Elashoff, R
Stern, SL
Nieweg, OE
Roses, DF
Karakousis, CP
Mozzillo, N
Reintgen, D
Wang, HJ
Glass, EC
Cochran, AJ
Citation: Dl. Morton et al., Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma - A multicenter trial, ANN SURG, 230(4), 1999, pp. 453-463
Authors:
Bass, SS
Dauway, E
Mahatme, A
Ku, NN
Berman, C
Reintgen, D
Cox, CE
Citation: Ss. Bass et al., Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers < 1 centimeter (T-1(A)-T-1(B)), AM SURG, 65(9), 1999, pp. 857-861